secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001213900-25-096322
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed receives $13M from Scilex in first tranche of warrant repurchase
-----------------------------------------------------------------------

- Scilex repurchased warrants for 3,130,000 shares of Scilex common stock for $13,000,000 on Sept 30, 2025.
- Scilex retains option to repurchase remaining 3,370,000 warrants for $14,000,000 by Dec 31, 2025.
- Total aggregate purchase price for both tranches is $27,000,000; original option agreement was filed July 23, 2025.
- Warrants repurchased have an exercise price of $0.01 per share of Scilex common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/0001213900-25-096322-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/ea0260371-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-096322

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer